Margetuximab Active Not Recruiting Phase 1 Trials for Malignant Neoplasm of Stomach / Breast Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01148849Safety Study of MGAH22 in HER2-positive Carcinomas